Cibus, Inc. (CBUS) shareholders
Close on Nov 17, 2026Market cap $106.24MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Rory B. Riggs | 18,726,128 | 33.02% | 13D (active) amendment | Sep 18, 2024 |
| Abigail P. Johnson Joint filing with FMR LLC (15.00%) | 11,425,929 | 15.00% | 13G (passive) amendment | Mar 31, 2026 |
| FMR LLC Joint filing with Abigail P. Johnson (13.90%) | 7,319,174 | 13.90% | 13G (passive) amendment | Dec 31, 2025 |
| Armistice Capital, LLC Joint filing with Steven Boyd (5.97%) | 1,948,000 | 5.97% | 13G (passive) | Mar 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of CBUS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FMR LLC | 11,449,660 | 14.98% | $15.69M | +23,731 | 0.00% |
| Vanguard Capital Management LLC | 2,299,966 | 3.01% | $3.15M | +181,470 | 0.00% |
| United Capital Financial Advisers, LLC | 576,043 | 0.75% | $789.18K | – | 0.00% |
| Geode Capital Management, LLC | 528,233 | 0.69% | $723.91K | +45,324 | 0.00% |
| BlackRock, Inc. | 492,795 | 0.64% | $675.13K | +77,619 | 0.00% |
| Certior Financial Group, LLC | 337,710 | 0.44% | $462.66K | +19,507 | 0.25% |
| Prescott Group Capital Management, L.L.C. | 328,157 | 0.43% | $449.58K | – | 0.04% |
| Squarepoint Ops LLC | 312,340 | 0.41% | $427.91K | +237 | 0.00% |
| Vanguard Fiduciary Trust Co | 310,136 | 0.41% | $424.89K | +51,988 | 0.00% |
| Corient Private Wealth LLC | 164,974 | 0.22% | $226.02K | – | 0.00% |
| State Street Corp | 157,189 | 0.21% | $215.35K | – | 0.00% |
| LPL Financial LLC | 142,431 | 0.19% | $195.13K | +37,138 | 0.00% |
| Renaissance Technologies LLC | 132,500 | 0.17% | $181.53K | +33,600 | 0.00% |
| Northern Trust Corp | 130,935 | 0.17% | $179.38K | +26,224 | 0.00% |
| Capital Advisor Network LLC | 129,975 | 0.17% | $178.07K | +52,351 | 0.22% |
| Lynx Capital Group Ltd /Adv | 74,000 | 0.10% | $101.38K | +20,000 | 0.04% |
| Summit Trail Advisors, LLC | 69,114 | 0.09% | $94.69K | – | 0.00% |
| Citigroup Inc | 63,564 | 0.08% | $87.08K | +50,291 | 0.00% |
| Moneta Group Investment Advisors LLC | 59,474 | 0.08% | $81.48K | New | 0.00% |
| Millennium Management LLC | 59,004 | 0.08% | $80.84K | −366,038 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 62 | 19M | 24.2% | 13 / 18 | 12 / 17 | 1M | 4M |
| Q1 2026 | 66 | 22M | 28.7% | 30 / 22 | 6 / 12 | 13M | 0M |
| Q4 2025 | 51 | 12M | 15.9% | 11 / 13 | 14 / 12 | 1M | 0M |
| Q3 2025 | 53 | 11M | 15.0% | 7 / 9 | 19 / 15 | 0M | 2M |
| Q2 2025 | 61 | 13M | 16.6% | 17 / 14 | 17 / 24 | 4M | 4M |
| Q1 2025 | 69 | 12M | 15.8% | 9 / 24 | 15 / 10 | 3M | 0M |
| Q4 2024 | 71 | 10M | 12.4% | 21 / 28 | 10 / 8 | 1M | 0M |
| Q3 2024 | 60 | 9M | 11.7% | 16 / 22 | 5 / 12 | 2M | 1M |
| Q2 2024 | 57 | 8M | 10.9% | 21 / 18 | 8 / 15 | 3M | 1M |
| Q1 2024 | 51 | 6M | 8.2% | 19 / 15 | 6 / 3 | 1M | 0M |
| Q4 2023 | 35 | 6M | 7.4% | 11 / 13 | 4 / 7 | 1M | 0M |
| Q3 2023 | 31 | 5M | 6.2% | 13 / 6 | 4 / 8 | 1M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
21 funds held CBUS in Q2 2026, 27% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of CBUS | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Growth Company Fund | 3,403,624 | 4.45% | $4.90M | 0.00% | May 31, 2026 |
| Vanguard Total Stock Market Index Fund | 1,602,469 | 2.10% | $2.20M | 0.00% | Jun 30, 2026 |
| Fidelity Growth Company K6 Fund | 974,876 | 1.28% | $1.40M | 0.01% | May 31, 2026 |
| Fidelity Series Growth Company Fund | 848,828 | 1.11% | $1.22M | 0.00% | May 31, 2026 |
| Fidelity Blue Chip Growth Fund | 713,362 | 0.93% | $1.38M | 0.00% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 637,314 | 0.83% | $873.12K | 0.00% | Jun 30, 2026 |
| iShares Micro-Cap ETF | 196,886 | 0.26% | $269.73K | 0.02% | Jun 30, 2026 |
| Fidelity Series Blue Chip Growth Fund | 133,771 | 0.18% | $258.18K | 0.00% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 131,371 | 0.17% | $189.17K | 0.00% | May 31, 2026 |
| Fidelity Blue Chip Growth K6 Fund | 120,908 | 0.16% | $233.35K | 0.00% | Jul 31, 2026 |
| Fidelity Total Market Index Fund | 61,483 | 0.08% | $88.54K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 59,962 | 0.08% | $86.35K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 43,620 | 0.06% | $62.81K | 0.00% | May 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 30,652 | 0.04% | $41.99K | 0.00% | Jun 30, 2026 |
| Vanguard Balanced Index Fund | 29,531 | 0.04% | $40.46K | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Carlo Broos | CFO | 225,935 | 0.30% | Nov 13, 2026 |
| Jason Stokes | CAO, Gen Csl & Corp Secy | 164,346 | 0.22% | Nov 13, 2026 |
| Noel Sauer | Sr VP, Research | 138,040 | 0.18% | Nov 13, 2026 |
| Craig Wichner | CEO | 894,309 | 1.17% | Jun 10, 2026 |
| Peter Beetham | Interim CEO, Pres & COO | 686,825 | 0.90% | Apr 28, 2026 |
| Gregory Francis William Gocal | Chief Scientific Officer & EVP | 422,890 | 0.55% | Apr 28, 2026 |
| Rory B. Riggs | Director | 14,982,312 | 19.60% | Jun 4, 2026 |
| Kimberly Ann Box | Director | 0 | – | Jun 4, 2026 |
| August J. Moretti | Director | 0 | – | Jun 4, 2026 |
| Mark Terrence Finn | Director | 2,951,382 | 3.86% | Jun 4, 2026 |
| Jean-Pierre Jules Lehmann | Director | 2,450,975 | 3.21% | Jun 4, 2026 |
| Gerhard Prante | Director | 104,945 | 0.14% | Jun 4, 2026 |
| Thomas Urban | Director | 64,748 | 0.08% | Jun 4, 2026 |
| Keith Allen Walker | Director | 98,701 | 0.13% | May 27, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Noel Sauer Sr VP, Research | Nov 11, 2026 | Tax withholding | −1,839 | $1.16 | $2.13K | 138,040 |
| Jason Stokes CAO, Gen Csl & Corp Secy | Nov 11, 2026 | Tax withholding | −3,519 | $1.16 | $4.08K | 164,346 |
| Carlo Broos CFO | Nov 11, 2026 | Tax withholding | −2,537 | $1.16 | $2.94K | 151,738 |
| Craig Wichner CEO | Jun 8, 2026 | Award | +894,309 | – | – | 894,309 |
| Gerhard Prante Director | Jun 2, 2026 | Award | +64,748 | – | – | 104,945 |
| Thomas Urban Director | Jun 2, 2026 | Award | +64,748 | – | – | 64,748 |
| Jean-Pierre Jules Lehmann Director | Jun 2, 2026 | Award | +64,748 | – | – | 763,904 |
| Gregory Francis William Gocal Chief Scientific Officer & EVP | Apr 24, 2026 | Award | +57,000 | – | – | 422,890 |
| Carlo Broos CFO | Apr 24, 2026 | Award | +57,000 | – | – | 154,275 |
| Peter Beetham Interim CEO, Pres & COO | Apr 24, 2026 | Award | +195,000 | – | – | 686,825 |
| Jason Stokes CAO, Gen Csl & Corp Secy | Apr 24, 2026 | Award | +57,000 | – | – | 167,865 |
| Carlo Broos CFO | Apr 24, 2026 | Award | +57,000 | – | – | 154,275 |
| Noel Sauer Sr VP, Research | Apr 24, 2026 | Award | +38,000 | – | – | 139,879 |
| Jason Stokes CLO, Gen Csl & Secy | Mar 30, 2026 | Tax withholding | −3,695 | $1.83 | $6.76K | 110,865 |
| Carlo Broos CFO | Mar 30, 2026 | Tax withholding | −3,676 | $1.87 | $6.87K | 97,275 |
| Peter Beetham Interim CEO, Pres & COO, Director | Mar 30, 2026 | Tax withholding | −16,112 | $1.85 | $29.81K | 491,825 |
| Noel Sauer Sr VP, Research | Mar 30, 2026 | Tax withholding | −1,763 | $1.84 | $3.24K | 101,879 |
| Gregory Francis William Gocal Chief Scientific Officer & EVP | Mar 30, 2026 | Tax withholding | −8,954 | $1.82 | $16.30K | 365,890 |
| Jason Stokes CLO, Gen Csl & Secy | Feb 19, 2026 | Tax withholding | −4,795 | $2.98 | $14.29K | 114,560 |
| Jean-Pierre Jules Lehmann Director | Jan 29, 2026 | Award | +666,666 | $1.50 | $1,000.00K | 699,156 |
| Rory B. Riggs Director, 10% owner | Jan 29, 2026 | Award | +333,333 | $1.50 | $500.00K | 14,916,640 |
| Carlo Broos CFO | Nov 11, 2025 | Tax withholding | −1,496 | $1.32 | $1.97K | 100,951 |
| Noel Sauer Sr VP, Research | Nov 11, 2025 | Tax withholding | −1,834 | $1.32 | $2.42K | 103,642 |
| Jason Stokes CLO, Gen Csl & Secy | Nov 11, 2025 | Tax withholding | −3,519 | $1.32 | $4.65K | 119,355 |
| Noel Sauer Sr VP, Research | Jun 13, 2025 | Sale | −4 | $1.49 | $6 | 105,476 |
| Rory B. Riggs Director, 10% owner | Jun 9, 2025 | Option exercise | +50,000 | $0.01 | $500 | 14,583,307 |
| Rory B. Riggs Director, 10% owner | Jun 9, 2025 | Option exercise | +4,000,000 | – | – | 14,533,307 |
| Rory B. Riggs Director, 10% owner | Jun 5, 2025 | Award | +5,714,286 | $1.75 | $10.00M | 10,533,307 |
| Gerhard Prante Director | May 22, 2025 | Award | +32,490 | – | – | 40,197 |
| Jean-Pierre Jules Lehmann Director | May 22, 2025 | Award | +32,490 | – | – | 32,490 |
| Jason Stokes CLO, Gen Csl & Secy | Mar 24, 2025 | Award | +28,250 | – | – | 127,669 |
| Noel Sauer SVP, Research | Mar 24, 2025 | Award | +11,750 | – | – | 105,480 |
| Gregory Francis William Gocal Chief Scientific Officer & EVP | Mar 24, 2025 | Award | +60,000 | – | – | 374,844 |
| Carlo Broos Interim CFO | Mar 24, 2025 | Award | +28,250 | – | – | 102,447 |
| Peter Beetham President and COO, Director | Mar 24, 2025 | Award | +125,500 | – | – | 507,937 |
| Gerhard Prante Director | Feb 25, 2025 | Sale(10b5-1 plan) | −1,150 | $1.92 | $2.21K | 7,707 |
| Gerhard Prante Director | Feb 24, 2025 | Sale(10b5-1 plan) | −1,150 | $2.07 | $2.38K | 8,857 |
| Gerhard Prante Director | Feb 21, 2025 | Sale(10b5-1 plan) | −1,150 | $2.20 | $2.53K | 10,007 |
| Gerhard Prante Director | Feb 20, 2025 | Sale(10b5-1 plan) | −1,150 | $2.35 | $2.70K | 11,157 |
| Jason Stokes CLO, Gen Csl & Secy | Feb 19, 2025 | Tax withholding | −4,795 | $2.33 | $11.17K | 122,874 |
| Gerhard Prante Director | Feb 19, 2025 | Sale(10b5-1 plan) | −1,150 | $2.58 | $2.97K | 12,307 |
| Gerhard Prante Director | Feb 18, 2025 | Sale(10b5-1 plan) | −1,150 | $2.52 | $2.90K | 14,607 |
| Gerhard Prante Director | Feb 18, 2025 | Sale(10b5-1 plan) | −1,150 | $2.52 | $2.90K | 13,457 |
| Gerhard Prante Director | Feb 14, 2025 | Sale(10b5-1 plan) | −1,150 | $2.60 | $2.99K | 15,757 |
| Gerhard Prante Director | Feb 13, 2025 | Sale(10b5-1 plan) | −1,150 | $2.53 | $2.91K | 16,907 |
| Gerhard Prante Director | Feb 12, 2025 | Sale(10b5-1 plan) | −1,150 | $2.45 | $2.82K | 18,057 |
| Gerhard Prante Director | Feb 11, 2025 | Sale(10b5-1 plan) | −1,150 | $2.48 | $2.85K | 19,207 |
| Gerhard Prante Director | Feb 10, 2025 | Sale(10b5-1 plan) | −1,150 | $2.52 | $2.90K | 20,357 |
| Gerhard Prante Director | Feb 7, 2025 | Sale(10b5-1 plan) | −1,150 | $2.50 | $2.88K | 21,507 |
| Gerhard Prante Director | Feb 6, 2025 | Sale(10b5-1 plan) | −1,150 | $2.55 | $2.93K | 22,657 |
| Gerhard Prante Director | Feb 5, 2025 | Sale(10b5-1 plan) | −1,150 | $2.52 | $2.90K | 23,807 |
| Gerhard Prante Director | Feb 4, 2025 | Sale(10b5-1 plan) | −1,150 | $2.45 | $2.82K | 24,957 |
| Gerhard Prante Director | Feb 3, 2025 | Sale(10b5-1 plan) | −1,150 | $2.41 | $2.77K | 26,107 |
| Gerhard Prante Director | Jan 31, 2025 | Sale(10b5-1 plan) | −1,150 | $2.55 | $2.93K | 27,257 |
| Gerhard Prante Director | Jan 30, 2025 | Sale(10b5-1 plan) | −1,150 | $2.46 | $2.83K | 28,407 |
| Gerhard Prante Director | Jan 29, 2025 | Sale(10b5-1 plan) | −1,150 | $2.42 | $2.78K | 29,557 |
| Gerhard Prante Director | Jan 28, 2025 | Sale(10b5-1 plan) | −1,150 | $2.44 | $2.81K | 30,707 |
| Gerhard Prante Director | Jan 27, 2025 | Sale(10b5-1 plan) | −1,150 | $2.37 | $2.73K | 31,857 |
| Gerhard Prante Director | Jan 24, 2025 | Sale(10b5-1 plan) | −1,150 | $2.60 | $2.99K | 33,007 |
| Gerhard Prante Director | Jan 23, 2025 | Sale(10b5-1 plan) | −1,150 | $2.59 | $2.98K | 34,157 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Cibus's stock actually held short. Settlement fails (shares not delivered on time) peaked at 19,769 shares on Sep 4, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Gerhard Prante Director | Nov 18, 2024 | 71,785 | $343.13K | Nov 18, 2024 | Received as consideration in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated 1/13/2023 (as amended), by and among the Issuer, Calypso Merger Sub |
| Greg Gocal Officer | Jun 27, 2024 | 18,000 | $163.08K | Jun 27, 2024 | Restricted Stock Units |
See a number that looks wrong?